Statistics for Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia
Total visits
| views | |
|---|---|
| Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia | 284 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| Zhang_2016_Pharmacokinetics.pdf | 314 |
Top country views
| views | |
|---|---|
| United States | 193 |
| Germany | 21 |
| United Kingdom | 8 |
| Ukraine | 5 |
| China | 3 |
| France | 3 |
| Japan | 3 |
| Russia | 3 |
| Canada | 2 |
| Italy | 2 |
| India | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 62 |
| Fairfield | 16 |
| Kiez | 16 |
| Ann Arbor | 11 |
| Cambridge | 9 |
| Houston | 8 |
| Jacksonville | 7 |
| Washington | 7 |
| White Plains | 6 |
| Kiev | 5 |
| Baltimore | 4 |
| Munich | 3 |
| Paris | 3 |
| Philadelphia | 3 |
| Saint Petersburg | 3 |
| San Francisco | 3 |
| Beijing | 2 |
| Brooklyn | 2 |
| Gaithersburg | 2 |
| Gunzenhausen | 2 |
| Salford | 2 |
| Toronto | 2 |
| Waterford | 2 |
| Alexandria | 1 |
| Amherst | 1 |
| Belvedere Tiburon | 1 |
| Bloomington | 1 |
| Chicago | 1 |
| Cincinnati | 1 |
| Cleveland | 1 |
| Genova | 1 |
| Grùmolo | 1 |
| Hillsborough | 1 |
| Johnston | 1 |
| Kansas City | 1 |
| Kyowa | 1 |
| Lake Mary | 1 |
| Mcdonough | 1 |
| Mountain View | 1 |
| Saint Paul | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Tustin | 1 |
| York | 1 |